Recent Dose posts
Over the past couple of years, many people have been frustrated by the rising cost EpiPens—the life-saving medication that counteracts severe allergic—which has soared from approximately $100 in 2008 to around $500 or more this year. Thanks to some industrious parents' use of social media, this is no longer happening under the radar. The traditional media beast is gorging on this outrage, which has been marked by head-turning developments seemingly on a daily basis. Senators and members of Congress are clamoring for congressional hearings. Heather Bresch, the CEO of Mylan, which produces EpiPens, has been getting the kind of lambasting that Martin Shkreli, who was skewered last year for raising the price of Daraprim 5,000 percent, endured.